Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040846
Status:
COMPLETED
Last Update Posted:
2020-01-29
First Post:
2002-07-08
Brief Title:
Alemtuzumab Fludarabine Phosphate and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Adult Nasal Type Extranodal NKT-cell Lymphoma |
| Anaplastic Large Cell Lymphoma |
| Angioimmunoblastic T-cell Lymphoma |
| Childhood Burkitt Lymphoma |
| Childhood Chronic Myelogenous Leukemia |
| Childhood Diffuse Large Cell Lymphoma |
| Childhood Immunoblastic Large Cell Lymphoma |
| Childhood Nasal Type Extranodal NKT-cell Lymphoma |
| Chronic Phase Chronic Myelogenous Leukemia |
| Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma |
| Contiguous Stage II Grade 1 Follicular Lymphoma |
| Contiguous Stage II Grade 2 Follicular Lymphoma |
| Contiguous Stage II Marginal Zone Lymphoma |
| Contiguous Stage II Small Lymphocytic Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Hepatosplenic T-cell Lymphoma |
| MyelodysplasticMyeloproliferative Neoplasm Unclassifiable |
| Nodal Marginal Zone B-cell Lymphoma |
| Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma |
| Noncontiguous Stage II Grade 1 Follicular Lymphoma |
| Noncontiguous Stage II Grade 2 Follicular Lymphoma |
| Noncontiguous Stage II Marginal Zone Lymphoma |
| Noncontiguous Stage II Small Lymphocytic Lymphoma |
| Peripheral T-cell Lymphoma |
| Previously Treated Myelodysplastic Syndromes |
| Progressive Hairy Cell Leukemia Initial Treatment |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Adult Burkitt Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Diffuse Mixed Cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Grade III Lymphomatoid Granulomatosis |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult Immunoblastic Large Cell Lymphoma |
| Recurrent Adult Lymphoblastic Lymphoma |
| Recurrent Adult T-cell LeukemiaLymphoma |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Recurrent Childhood Anaplastic Large Cell Lymphoma |
| Recurrent Childhood Large Cell Lymphoma |
| Recurrent Childhood Lymphoblastic Lymphoma |
| Recurrent Childhood Small Noncleaved Cell Lymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Mycosis FungoidesSezary Syndrome |
| Recurrent Small Lymphocytic Lymphoma |
| RecurrentRefractory Childhood Hodgkin Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Refractory Hairy Cell Leukemia |
| Refractory Multiple Myeloma |
| Relapsing Chronic Myelogenous Leukemia |
| Splenic Marginal Zone Lymphoma |
| Stage I Adult Diffuse Small Cleaved Cell Lymphoma |
| Stage I Childhood Anaplastic Large Cell Lymphoma |
| Stage I Childhood Large Cell Lymphoma |
| Stage I Cutaneous T-cell Non-Hodgkin Lymphoma |
| Stage I Grade 1 Follicular Lymphoma |
| Stage I Grade 2 Follicular Lymphoma |
| Stage I Mantle Cell Lymphoma |
| Stage I Marginal Zone Lymphoma |
| Stage I Mycosis FungoidesSezary Syndrome |
| Stage I Small Lymphocytic Lymphoma |
| Stage II Childhood Anaplastic Large Cell Lymphoma |
| Stage II Childhood Large Cell Lymphoma |
| Stage II Cutaneous T-cell Non-Hodgkin Lymphoma |
| Stage II Mycosis FungoidesSezary Syndrome |
| Stage III Adult Diffuse Large Cell Lymphoma |
| Stage III Adult Diffuse Small Cleaved Cell Lymphoma |
| Stage III Childhood Anaplastic Large Cell Lymphoma |
| Stage III Childhood Large Cell Lymphoma |
| Stage III Cutaneous T-cell Non-Hodgkin Lymphoma |
| Stage III Grade 1 Follicular Lymphoma |
| Stage III Grade 2 Follicular Lymphoma |
| Stage III Mantle Cell Lymphoma |
| Stage III Marginal Zone Lymphoma |
| Stage III Mycosis FungoidesSezary Syndrome |
| Stage III Small Lymphocytic Lymphoma |
| Stage IV Adult Diffuse Large Cell Lymphoma |
| Stage IV Adult Diffuse Small Cleaved Cell Lymphoma |
| Stage IV Childhood Anaplastic Large Cell Lymphoma |
| Stage IV Childhood Large Cell Lymphoma |
| Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma |
| Stage IV Grade 1 Follicular Lymphoma |
| Stage IV Grade 2 Follicular Lymphoma |
| Stage IV Mantle Cell Lymphoma |
| Stage IV Marginal Zone Lymphoma |
| Stage IV Mycosis FungoidesSezary Syndrome |
| Stage IV Small Lymphocytic Lymphoma |
| T-cell Large Granular Lymphocyte Leukemia |
| Waldenström Macroglobulinemia |
Keywords: